ProDerMA
ProDerMA, licence 80102931: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- Derma Heel, Derma Vita, Pro Cutis, Pro Derm, ProDerma
- Licence holder
- Propharmex Inc.
- NPN or DIN-HM
- 80102931
- Status
- Active licence
- Licence date
- 21 July 2020
- Revision date
- 23 April 2021
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| (11bêta)-11,17,21-trihydroxy-prégn-4-ène-3,20-dione Source : Hydrocortisone | 1.0 % | Not calculated |
Non-medicinal ingredients
Lauryl sulfate de sodium, Eau purifiée, (p)-hydroxybenzoate de propyle, Acide citrique, Alcool cétostéarylique, Cire d'abeille synthétique, Huile minérale légère, (p)-hydroxybenzoate de méthyle, Alcool stéarylique, Glycérine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | 1.0 Crème | minimum: 3.0 Tous les jours ; maximum: 4.0 Tous les jours |
| Adolescentes | minimum: 12.0 Année(s) ; maximum: 17.0 Année(s) | 1.0 Crème | minimum: 3.0 Tous les jours ; maximum: 4.0 Tous les jours |
Uses authorised in Canada
Anti-itch. Anti-pruritic. For temporary relief of (external) feminine genital itching and/or (external) anal itching (due to hemorrhoids). For temporary relief of minor skin irritations, rashes, itching and redness (due to eczema, insect bites, poison ivy, poison oak, poison sumac, seborrheic dermatitis, psoriasis, or contact dermatitis) (e.g. caused by soaps, detergents, cosmetics and/or jewellery)). For temporary relief of minor skin irritations associated with redness, itching, dryness and scaling.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use this product for the treatment of diaper rash, except on the advice of a health care practitioner/health care provider/health care professional/doctor/physician. Do not use this product in or around the eyes or on large areas of the body. Do not use this product to treat vulvar itching associated with a vaginal discharge, except on the advice of a health care practitioner/health care provider/health care professional/doctor/physician.
- Précautions et mises en garde
For external use only. Stop use and do not begin use of any other hydrocortisone product, except on the advice of a health care practitioner/health care provider/health care professional/doctor/physician, if symptoms worsen or persist more than 7 days or clear up and occur again within a few days.
Source
Official Health Canada record, licence 80102931
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2021. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.